Skip Navigation

European Heart Journal 2002 23(19):1492-1502; doi:10.1053/euhj.2002.3189
Copyright © 2002 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Tandar, A.
Right arrow Articles by Spodick, D.H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tandar, A.
Right arrow Articles by Spodick, D.H.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Reviews

Direct myocardial revascularization and therapeutic angiogenesis

A. Tandar, G.M. Saperia and D.H. Spodickf1

Department of Medicine, Saint Vincent Hospital, Worcester Medical Center , Worcester, Massachusetts, U.S.A.

Key Words: Direct myocardial revascularization, therapeutic angiogenesis, combination

f1 Correspondence: David H. Spodick, MD, Saint Vincent Hospital-Worcester Medical Center, Department of Medicine, Division of Cardiology, 20 Worcester Central Boulevard, Worcester, MA 01608, U.S.A.

References

  1. Pratt FH. The nutrition of the heart through the vessels of thebesius and the coronary veins. Am J Physiol. 1898;1:86–103[Free Full Text]
  2. Wearn JT, Mettier SR, Klump TG. The nature of vascular communications between the coronary arteries and the chambers of the heart. Am Heart J. 1933;9:143–164[CrossRef]
  3. Sen PK, Udwadia TE, Kinore SG. Transmyocardial acupuncture: a new approach to myocardial revascularization. J Thorac Cardiovasc Surg. 1956;50:181–189
  4. Kornowski R, Hong MK, Leon MB. Current perspective on direct myocardial revascularization. Am J Cardiol. 1998;81:44E–48E[CrossRef][ISI][Medline]
  5. Kim CB, Oesterle SN. Percutaneous transmyocardial revascularization. J Clin Laser Med Surg. 1997;15:293–298[Medline]
  6. Hughes GC, Abdel-aleem S, Biswas SS. Transmyocardial laser revascularization: Experimental and clinical results. Can J Cardiol. 1999;5:797–806
  7. Kaul U, Shawl F, Singh B. Percutaneous transmyocardial revascularization with a Holium Laser System: procedural results and early clinical outcome. Cath Cardiovasc Intervent. 1999;47:287–291[CrossRef]
  8. Braunwald E. Heart Disease: The Textbook Cardiovascular Medicine. Philadelphia: Saunders; 1997.
  9. Abramov D, Bhatnagar G, Tamariz M. Current status of transmyocardial laser revascularization: review of literature. Can J Cardiol. 1999;15:303–310[ISI][Medline]
  10. Baim, DS, Carrozza, Laham, RJ, DMR Phase II Trial (DIRECT) Protocol, Beth Israel Deaconess Medical Center–Harvard Medical School, 1999
  11. Mirhoseini M, Mucherbeide M, Cayton MM. Transmyocardial revascularization by laser. Laser Surg Med. 1982;2:187–198
  12. Horvarth KA, Cohn LH, Cooley DA. Transmyocardial laser revascularization: Results of multicenter trial with transmyocardial laser revascularization used as sole therapy for end-stage coronary disease. J Thorac Cardiovasc Surg. 1997;113:645–653[Abstract/Free Full Text]
  13. Owen ER, Canfeld. Observation on the effect of CO2-laser on rat myocardium. Microsurgery. 1984;5:140–143[Medline]
  14. Oesterle SN, Sanborn TA, Ali N, Resar J. Percutaneous transmyocardial laser revascularization for severe angina: the PACIFIC randomized trial. Potential class improvement from intramyocardial channels. Lancet. 2000;356:1705–1710[CrossRef][ISI][Medline]
  15. Milano A, Pratali S, Tartarini G. Early results of transmyocardial revascularization with a holmium laser. Am J Thorac Surg. 1998;65:700–704[Abstract/Free Full Text]
  16. Lauer B, Junghans UB, Stahl F. Catheter based percutaneous myocardial laser revascularization in patients with end-stage coronary artery disease. J Am Coll Cardiol. 1999;34:1663–1670[Abstract/Free Full Text]
  17. Landolfo CK, Landolfo KP, Hughes GC. Intermediate-term clinical outcome following transmyocardial laser revascularization in patients with refractory angina pectoris. Circulation. 1999;100:II128–33
  18. Allen KB, Dowling RD, Fudge TL. Comparison of transmyocardial revascularization with medical therapy in patients with refractory angina. N Engl J Med. 1999;341:1029–1036[Abstract/Free Full Text]
  19. Hardy RI, Bove KE, James FW. A Histologic study of laser-induced transmyocardial channels. Lasers Surg Med. 1987;6:563–573[ISI][Medline]
  20. Frazier OH, Cooley DA, Kadipasaoglu KA. Myocardial revascularization with laser. Preliminary findings. Circulation. 1995;92:1158–1165
  21. Mori H, Tanaka E, Hyodo K. Synchroton microangiography reveals configurational changes and to-and-fro flow in intramyocardial vessels. Am Phy Society. 1999;H:429–437
  22. Kwong KF, Kanellopoulos GK, Nickols JC. Transmyocardial Revascularization treatment denervates canine myocardium. J Thoracic Cardiovasc Surg. 1997;114:883–889[Abstract/Free Full Text]
  23. Al-Sheikh T, Allen KB, Straka SP. Cardica sympathetic denervation after transmyocardial laser revascularization. Circulation. 1999;100:135–140[Abstract/Free Full Text]
  24. Schoebel FC, Frazier OH, Jessurum GA. Refractory angina pectoris in end-stage coronary artery disease: evolving therapeutic concepts. Am Heart J. 1997;134:587–602[CrossRef][ISI][Medline]
  25. Leon, MB, Baim, DS, DMR in regeneration endomyocardial channels trial
  26. Isner JM. Angiogenesis. Comprehensive Cardiovascular Medicine. Philadelphia: Lippincot-Raven; 1998. p. 2973–3000
  27. Beck L Jr, D'Amore P. Vascular development: cellular and molecular regulation. FASEB J. 1997;11:365–373[Abstract]
  28. Folkman J. Tumor angiogenesis: therapeutic implication. N Engl J Med. 1971;285:1182–1186[ISI][Medline]
  29. Marti HJ, Bernaudin M, Bellail A. Hypoxia-induced vascular endothelial growth factor expression precedes neovascularization after cerebral ischemia. Am J Pathol. 2000;156:965–976[Abstract/Free Full Text]
  30. Brooks PC, Clark RAF, Cheresh DA. Requirement of vascular integrin {alpha}vß3 for angiogenesis. Science. 1994;264:569–571[Abstract/Free Full Text]
  31. Davis S, Aldrich TH, Jones PF. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell. 1996;17:1161–1169
  32. Lee SH, Wolf PL, Escudero R. Early expression of angiogenesis factors in acute myocardial ischemia and infarction. N Eng J Med. 2000;342:626–633[Abstract/Free Full Text]
  33. Aranki SF. Transmyocardial laser revascularization: Subjective success, objective controversy. Cardiology Rounds. 2000;4:1
  34. Chu VF, Giaid A, Kuang JQ. Angiogenesis in transmyocardial revascularization: comparison of laser versus mechanical punctures. Ann Thorac Surg. 1999;68:301–307[Abstract/Free Full Text]
  35. Kohmoto T, DeRosa CM, Yamamoto N. Evidence of vascular growth associated with laser treatment of normal canine myocardium. Ann Thorac Surg. 1998;65:1360–1367[Abstract/Free Full Text]
  36. Lee LY, Rosengart TK. Transmyocardial laser revascularization and angiogenesis: the potential for therapeutic benefit. Sem Thoracic and Cardiovasc Surg. 1999;11:29–35
  37. Henry TD. Therapeutic angiogenesis. BMJ. 1999;318:1536–1539[Free Full Text]
  38. Laham RJ, Hung D, Simons M. Therapeutic myocardial angiogenesis using percutaneous intrapericardial drug delivery. Clin Cardiol. 1999;22:I6–9[ISI][Medline]
  39. Takeshita S, Zheng LP, Brogi E. Therapeutic Angiogenesis: A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hindlimb model. J Clin Invest. 1994;93:662–670[ISI][Medline]
  40. Baffour B, Berman J, Garb JL. Enhanced angiogenesis and growth of collaterals by in vivo administration of recombinant basic FGF in a rabbit model of acute lower limb ischemia: dose dependent effect of bFGF. Vasc Surg. 1992;16:182–191
  41. Losordo DW, Vale PR, Symes JF. Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia. Circulation. 1998;98:2800–2804[Abstract/Free Full Text]
  42. Isner JM, Pieczek A, Schainfeld R. Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in a patient with ischemic limb. Lancet. 1996;348:370–374[CrossRef][ISI][Medline]
  43. Schumacher B, Pecher P, von Specht BM. Induction of neoangiogenesis in ischemic myocardium by human growth factor. Circulation. 1998;97:645–650[Abstract/Free Full Text]
  44. Kipshidze N, Johnson D, Haudenschild CC. Therapeutic angiogenesis in patients with advanced coronary artery disease: Hype or Hope? J Invas Cardiol. 1999;11:589–599[ISI][Medline]
  45. Rosengart TK, Lee LY, Patel SR. Six month assessment of a phase I trial of angiogenic gene therapy for the treatment of coronary artery disease using direct intramyocardial administration of an adenovirus vector expressing VEGF121cDNA. Ann Surg. 1999;230:466–470[CrossRef][ISI][Medline]
  46. Henry TD, Rocha-Singh K, Isner JM. Intracoronary administration of recombinant human vascular endothelial growth factor to patients with coronary artery disease. Am Heart J. 2001;142:872–880[CrossRef][ISI][Medline]
  47. Sayeed-Shah U, Reul RM, Byrne JG. Combination TMR and gene therapy. Semin Thoracic Cardiovasc Surg. 1999;11:36–39
  48. Kantor B, McKenna CJ, Caccitolo JA. Transmyocardial and percutaneous myocardial revascularization: current and future role in the treatment of coronary artery disease. Mayo Clin Proc. 1999;74:585–592[ISI][Medline]
  49. Fleischer KJ, Goldschmidt-Clermont J, Fonger JD. One-month histology response of transmyocardial laser channels with molecular intervention. Ann Thorac Surg. 1996;62:1051–1058[Abstract/Free Full Text]
  50. Yamamoto N, Kohmoto T, Roethy W. Histologic evidence that basic fibroblast growth factor enhances the angiogenic effects of transmyocardial laser revascularization. Basic Res Cardiol. 2000;95:55–63[CrossRef][ISI][Medline]
  51. Bao J, Narmark W, Palasis M. Intramyocardial delivery of FGF2 in combination with radiofre uency transmyocardial revascularization. Catheter Cardiovasc Interv. 2001;53:429–434[CrossRef][ISI][Medline]
  52. Mueller XM, Tevaearai HT, Geenton CY. Improved neoangiogenesis in transmyocardial laser revascularization combined with angiogenic adjunct in a pig model. Clin Sci (Colch). 2000;99:535–540[Medline]
  53. Hamawy AM, Lee LY, Samy SA. Transmyocardial laser revascularization dose response: enhanced perfusion in a porcine ischemia model as a function of channel density. Ann Thorac Surg. 2001;72:817–822[Abstract/Free Full Text]
  54. Drachman DE, Edelman ER, Seifert P. Neointimal thickening after stent delivery of Paclitaxel: change in composition and arrest of growth over 6 months. J Am Coll Cardiol. 2001;38:292–293[Free Full Text]
  55. Roethy W, Fiehn E, Suehiro K. A growth factor mixture that significantly enhances angiogenesis in vivo. J Pharmacol Exp Ther. 2001;299:494–500[Abstract/Free Full Text]

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?



This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Tandar, A.
Right arrow Articles by Spodick, D.H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tandar, A.
Right arrow Articles by Spodick, D.H.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?